Thus, our results reveal the mechanism under the effect of berberine on sarcopenia IR via PINK1/Parkin-inducing mitophagy, which provides a new paradigm to develop promising therapeutic strategies for sarcopenia IR. The gene discussed is PRKN; the disease is sarcopenia.